Abstracts that are considered to be late-breaking present novel research with results not fully available at the time of the general abstract submission deadline. Specifically, late-breaking abstracts report new and urgent findings that could not have been anticipated prior to the general abstract submission deadline or presented at a previous meeting. However, this category does not allow for resubmissions of abstracts that were previously submitted and accepted for the main e-poster sessions, including those with the following: case reports, qualitative surveys, practice reviews, rating scale validation, small confirmatory studies, and research proposals.
In addition, late-breaking abstracts that are deemed to have an impact on the field and will likely drive future advancements in the musculoskeletal diseases community are eligible for the Spotlight on Late Breaking Clinical Research sessions. These are special sessions in which authors have the opportunity to deliver a 12-minute oral presentation followed by 3 minutes of questions. The presenting author of an accepted late-breaking abstract must register for and attend the Congress to present on behalf of their group.
A presenting author may submit up to two late-breaking works (abstracts or posters) in total, but will only be allowed to present one of these works in an oral session or the Spotlight on Late Breaking Clinical Studies. All abstracts are reviewed by a panel of scientists, and the decision is based on the scientific merit of the work and its potential to advance the conference themes. Please review the CHI Anonymization Policy to ensure that your abstract does not include identifying information, such as authors’ names and institutions.
About the Author
